Highlights and Quick Summary
- Trade and Non-Trade Receivables Growth for the quarter ending June 30, 2023 was 0.66 (a -561.54% decrease compared to previous quarter)
- Year-over-year quarterly Trade and Non-Trade Receivables Growth decreased by -364.56%
- Annual Trade and Non-Trade Receivables Growth for 2022 was -0.42 (a -323.19% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2021 was 0.19 (a -229.05% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2020 was -0.15 (a 9700.0% increase from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Trade and Non-Trade Receivables Growth of Emergent Biosolutions Inc.
Most recent Trade and Non-Trade Receivables Growthof EBS including historical data for past 10 years.Interactive Chart of Trade and Non-Trade Receivables Growth of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Trade and Non-Trade Receivables Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.66 | -0.14 | – | – | – |
| 2022 | -0.42 | -0.25 | -0.33 | -0.01 | -0.42 |
| 2021 | 0.19 | 0.3 | 0.01 | 0.07 | 0.19 |
| 2020 | -0.15 | -0.3 | 0.19 | 0.42 | -0.15 |
| 2019 | -0.0 | 2.65 | 0.15 | -0.06 | -0.0 |
| 2018 | 0.86 | -0.41 | 0.74 | -0.04 | 0.86 |
| 2017 | -0.02 | 0.59 | 0.43 | 0.84 | -0.02 |
| 2016 | 0.23 | 0.35 | -0.33 | -0.1 | 0.23 |
| 2015 | 1.0 | 0.15 | 0.19 | 0.0 | 1.0 |
| 2014 | -0.09 | 0.71 | 0.56 | 0.1 | -0.09 |
| 2013 | -0.31 | 0.15 | 0.06 | 0.16 | -0.31 |
| 2012 | 0.15 | -0.64 | – | – | 0.15 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic